Sellam, Jérémie <br/><br/>
Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis.  [electronic resource] 

 -  Arthritis research & therapy  12 2016 
 - 294 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Observational Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1478-6362 
<br/><br/><label>Standard No.: </label>10.1186/s13075-016-1190-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Rheumatoid--blood<br/>Biomarkers--blood<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Humans<br/>Interleukin-33--blood<br/>Male<br/>Middle Aged<br/>Rituximab--therapeutic use<br/>Treatment Outcome